Project development teams: a novel mechanism for accelerating translational research

Tammy J Sajdyk1, Thomas G Sors, Joe D Hunt

  • 1Dr. Sajdyk is translational sciences research officer and research navigator, Indiana Clinical and Translational Sciences Institute, Indiana University, Indianapolis, Indiana. Dr. Sors is chief scientific liaison, Bindley Bioscience Center, and research navigator, Purdue University, West Lafayette, Indiana. Mr. Hunt is associate director of tracking and evaluation, Indiana Clinical and Translational Sciences Institute, Indiana University, Indianapolis, Indiana. Ms. Murray is translational research administrator and special projects coordinator, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana. Ms. Deford is director of grants business management, Office of Research, University of Notre Dame, South Bend, Indiana. Dr. Shekhar is director, Indiana Clinical and Translational Sciences Institute, assistant vice president for research, Indiana University, and professor of psychiatry, Indiana University School of Medicine, Indianapolis, Indiana. Dr. Denne is director, Project Development Team Program, and professor of pediatrics, Indiana University School of Medicine, Indianapolis, Indiana.

Summary

The Indiana Clinical and Translational Sciences Institute (Indiana CTSI) Project Development Teams (PDTs) program facilitates collaborative biomedical research. PDTs provide essential resources and expertise, accelerating the translation of ideas into successful research projects.

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.2K
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.7K
Initiation of Translation02:33

Initiation of Translation

Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
24.5K
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
4.5K
Improving Translational Accuracy02:07

Improving Translational Accuracy

Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
11.5K
Improving Translational Accuracy02:07

Improving Translational Accuracy

2.6K